IQVIA Holdings Inc. (IQV)
NYSE · Common stock · Services-Commercial Physical & Biological Research
As of Oct 21, 11:07 AM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.
Follow IQV in real time
Real-time quotes, Pro Charting, the scanner and the alert feed on IQV and every other US listing.
Start 5 days freeTry Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
IQV at a glance
Key statistics
$44.09B
Market capitalization
- Previous close
- $267.85
- Open
- $265.12
- Day range
- $263.98 – $274.25
- Volume
- 344.3K
- Average volume (30 sessions)
- 1.48M
- Shares outstanding
- 164.60M
- Price / earnings
- 32.1
- Earnings per share
- $8.35
- Price / book
- 7.1
- Price / sales
- 2.6
- Beta (1 year, vs SPY)
- 0.73
Where the price sits in its year
52-week range
97% of the range
- Below the 52-week high
- -1.5%
- Above the 52-week low
- +76.9%
Completed sessions through Oct 20, 2026
Technical snapshot
Above its 50-day and 200-day averages
- 20-day average
- $265.03+1.1%
- 50-day average
- $261.08+2.6%
- 200-day average
- $208.16+28.7%
Between the conventional 30 and 70 bands.
+2.8%
1 week
-0.8%
1 month
+34.9%
3 months
+18.8%
Year to date
+30.9%
1 year
Price change over each window, from completed sessions. Past performance does not indicate future results.
Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.The member platform, in real time
What members do with IQV
IQV on Pro Charting
Every intraday interval in real time, the drawing kit and the full set of technical studies on IQV.
See the plans →
Every planScreen names like IQV
The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.
See the plans →
Analysis Tools OnlySet a price line on IQV
Put IQV on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.
See the plans →
Stock Alerts + ToolsOpen alerts on IQV
See whether there is an open premium alert on IQV, with its entry, stop and exit, each one reviewed by an analyst before it is sent.
See the plans →
From the public news wire
IQV headlines
- AI in Clinical Settings Research Report 2024 and Global Forecasts 2025-2030 Featuring IQVIA, AiCure, Google, DeepScribe, Siemens Healthineers, Nuance Communications, Care.ai, Qure AI, NVIDIA, Arm
GlobeNewswire Inc. · Jan 30, 2025
- Large Molecule Bioanalytical Testing Services Market Size, Share & Trends Analysis Report 2025-2030, Featuring Laboratory Corporation of America, IQVIA, Syneous Health, SGS, WuXi AppTec and Other Major Players
GlobeNewswire Inc. · Dec 2, 2024
SEC Form 4, most recent first
Insider filings
Berkshire James G.
−5.4K
See Remarks · Option exercise
$709.32K · Sep 2, 2026
Berkshire James G.
+5.4K
See Remarks · Option exercise
$709.32K · Sep 2, 2026
Berkshire James G.
−2.7K
See Remarks · Open-market sale
$697.23K · Sep 2, 2026
Berkshire James G.
−2.7K
See Remarks · Returned to the company
$709.56K · Sep 2, 2026
Patel Bhavik
−1.9K
See Remarks · Open-market sale
$436.43K · Jul 31, 2026
STAUB W RICHARD
−5.5K
See Remarks · Open-market sale
$1.28M · Aug 3, 2026
BOUSBIB ARI
−4.6K
See Remarks, Director · Open-market sale
$1.13M · Jul 29, 2026
BOUSBIB ARI
−47.9K
See Remarks, Director · Returned to the company
$11.71M · Jul 29, 2026
About IQVIA Holdings Inc.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
- Exchange
- NYSE
- Security
- Common stock
- Industry
- Services-Commercial Physical & Biological Research
- Headquarters
- Durham, NC
- Employees
- 94,000
- Listed since
- May 9, 2013
- Website
- iqvia.com
Pick the desk that fits how you trade
Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.
Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.